Literature DB >> 10735616

Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis.

M Masseroli1, T Caballero, F O'Valle, R M Del Moral, A Pérez-Milena, R G Del Moral.   

Abstract

BACKGROUND/AIMS: Liver fibrosis is one of the most important and characteristic histologic alterations in progressive and chronic liver diseases. Thus, in both clinical and experimental practice, it is fundamental to have a reliable and objective method for its precise quantification. Several semi-quantitative scoring systems have been described. All are time-consuming and produce partially subjective fibrosis evaluations that are not very precise. This paper describes the design and validation of an original image analysis-based application, FibroQuant, for automatically and rapidly quantifying perisinusoidal, perivenular and portal-periportal and septal fibrosis and portal-periportal and septal morphology in liver histologic specimens.
METHODS: The implemented image-processing algorithms automatically segment interstitial fibrosis areas, while extraction of portal-periportal and septal region is carried out with an automatic algorithm and a simple interactive step. For validation, all automatically extracted areas were also manually segmented and quantified.
RESULTS: Statistical analysis showed significant intra- and interoperator variability in manual segmentation of all areas. Automatic quantifications did not significantly differ from mean manual evaluations of the same areas. Comparison of our image analysis quantifications with staging histologic evaluations of liver fibrosis showed significant correlations (Spearman's, 0.72<r<0.83; p<0.0001) and that the latter are based more on the distribution patterns than on the quantity of fibrosis.
CONCLUSIONS: FibroQuant is a sensitive, precise, objective and reproducible method of fibrosis quantification, which complements semi-quantitative histologic evaluation systems. This novel tool could be of special value in clinical trials and for improving the prognosis and follow-up among patients with fibrosis-inducing hepatic diseases.

Entities:  

Mesh:

Year:  2000        PMID: 10735616     DOI: 10.1016/s0168-8278(00)80397-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  25 in total

1.  Digital quantification is more precise than traditional semiquantitation of hepatic steatosis: correlation with fibrosis in 220 treatment-naïve patients with chronic hepatitis C.

Authors:  Sekou R Rawlins; Ola El-Zammar; J Michael Zinkievich; Nancy Newman; Robert A Levine
Journal:  Dig Dis Sci       Date:  2010-05-12       Impact factor: 3.199

Review 2.  An appraisal of the histopathological assessment of liver fibrosis.

Authors:  R A Standish; E Cholongitas; A Dhillon; A K Burroughs; A P Dhillon
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

3.  Metrically measuring liver biopsy: a chronic hepatitis B and C computer-aided morphologic description.

Authors:  Nicola Dioguardi; Fabio Grizzi; Barbara Fiamengo; Carlo Russo
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

4.  Sampling variability of computer-aided fractal-corrected measures of liver fibrosis in needle biopsy specimens.

Authors:  Fabio Grizzi; Carlo Russo; Barbara Franceschini; Mariagrazia Di Rocco; Valter Torri; Emanuela Morenghi; Luigi Rainiero Fassati; Nicola Dioguardi
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

Review 5.  Evolution of the liver biopsy and its future.

Authors:  Dhanpat Jain; Richard Torres; Romulo Celli; Jeremy Koelmel; Georgia Charkoftaki; Vasilis Vasiliou
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

6.  STING signalling protects against chronic pancreatitis by modulating Th17 response.

Authors:  Qinglan Zhao; Murli Manohar; Yi Wei; Stephen J Pandol; Aida Habtezion
Journal:  Gut       Date:  2019-01-31       Impact factor: 23.059

7.  Serum hyaluronic acid: a promising marker of hepatic fibrosis in chronic hepatitis B.

Authors:  Gamal Shiha
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

8.  Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis.

Authors:  Sebastian Huss; Jörg Schmitz; Diane Goltz; Hans-Peter Fischer; Reinhard Büttner; Ralf Weiskirchen
Journal:  Fibrogenesis Tissue Repair       Date:  2010-06-17

Review 9.  Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools.

Authors:  Yan Wang; Jin-Lin Hou
Journal:  Hepatol Int       Date:  2016-01-07       Impact factor: 6.047

10.  Intra-voxel incoherent motion MRI in rodent model of diethylnitrosamine-induced liver fibrosis.

Authors:  Yue Zhang; Ning Jin; Jie Deng; Yang Guo; Sarah B White; Guang-Yu Yang; Reed A Omary; Andrew C Larson
Journal:  Magn Reson Imaging       Date:  2013-04-15       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.